Experienced investor and corporate governance specialist focused on value-oriented public equities and activist engagements. Andrew Alkon has led investment teams and advised boards on capital allocation, restructuring and shareholder value initiatives. Known for pragmatic portfolio construction, event-driven catalysts and concentrated stakes, the profile suits allocators seeking managers with operational activism and fundamental research capabilities.
Experienced investor and corporate governance specialist focused on value-oriented public equities and activist engagements. Andrew Alkon has led investment teams and advised boards on capital allocation, restructuring and shareholder value initiatives. Known for pragmatic portfolio construction, event-driven catalysts and concentrated stakes, the profile suits allocators seeking managers with operational activism and fundamental research capabilities.
Seasoned value investor concentrating on underfollowed public equities, prioritizing deep fundamental research and catalyst-driven activism. Pursues concentrated, high-conviction stakes to influence capital allocation, board composition and strategic restructurings. Combines event-driven holding periods with long-term value realization, disciplined downside risk controls and active engagement to unlock shareholder value. Allocation bias toward cyclical, distressed and mispriced industrials, financials and corporate situations where operational insight creates asymmetric returns.
Seasoned value investor concentrating on underfollowed public equities, prioritizing deep fundamental research and catalyst-driven activism. Pursues concentrated, high-conviction stakes to influence capital allocation, board composition and strategic restructurings. Combines event-driven holding periods with long-term value realization, disciplined downside risk controls and active engagement to unlock shareholder value. Allocation bias toward cyclical, distressed and mispriced industrials, financials and corporate situations where operational insight creates asymmetric returns.
| Trades 8404 | Longs Won 4033/8404 47% | Profit Factor 1.91 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $64,525.42 |
| Average Win $40,231.98 | Best Trade (Dec 30) $1.78M | Sharpe Ratio -43.07 |
| Average Loss -$19,452.73 | Worst Trade (Aug 25) -$367,499.44 | Z-Score -2.57 (100%) |
| Commissions $0 | Avg. Trade Length 5m 5d | Expectancy $9,182.62 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 21,739 | 19,565 | 17,391 | 15,217 | 13,043 | 10,870 | 8,696 | 6,522 | 4,348 | 2,174 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 3,150 | $359,037.28 | $466,956 | - | $107,918.72 | 30.06% | 0.0 |
AAON Aaon Inc. | 7,424 | $614,335.85 | $632,747.52 | - | $18,411.67 | 3% | 0.0 |
ABEV Ambev S.A. | 16,169 | $39,937.35 | $45,596.58 | - | $5,659.23 | 14.17% | 0.0 |
ABM ABM Industries Inc. | 25,331 | $1.07M | $1.23M | - | $156,057.51 | 14.57% | 0.0 |
ABUS Arbutus Biopharma Corporation | 27,940 | $125,730.13 | $128,244.6 | - | $2,514.47 | 2% | 0.0 |
ACAD Acadia Pharmaceuticals Inc. | 12,819 | $278,027.59 | $363,803.22 | - | $85,775.63 | 30.85% | -3.633% |
ACEL Accel Entertainment Inc. | 16,964 | $196,629.42 | $209,335.76 | - | $12,706.34 | 6.46% | 0.0 |
ACGL Arch Capital Group Ltd | 9,389 | $886,045.8 | $920,403.67 | - | $34,357.87 | 3.88% | +0.761% |
ACIC American Coastal Insurance Corp. | 28,444 | $315,728 | $279,604.52 | - | -$36,123.48 | -11.44% | 0.0 |
ACM Aecom | 7,412 | $628,686 | $452,428.48 | - | -$176,257.52 | -28.04% | 0.0 |
ACVA ACV Auctions Inc. | 83,685 | $754,871.01 | $649,395.6 | - | -$105,475.41 | -13.97% | 0.0 |
ADEA Adeia Inc. | 13,453 | $232,064.19 | $378,163.83 | - | $146,099.64 | 62.96% | 0.0 |
ADMA Adma Biologics Inc. | 18,144 | $163,477.52 | $177,448.32 | - | $13,970.8 | 8.55% | 0.0 |
ADP Automatic Data Processing Inc. | 1,619 | $328,948.37 | $436,045.27 | - | $107,096.9 | 32.56% | 0.0 |
ADT ADT Inc. | 17,807 | $116,992 | $130,169.17 | - | $13,177.17 | 11.26% | 0.0 |
ADTN Adtran Holdings, Inc. | 30,252 | $362,749.5 | $246,856.32 | - | -$115,893.18 | -31.95% | 0.0 |
ADUS Addus HomeCare Corporation | 2,822 | $264,280 | $333,165.32 | - | $68,885.32 | 26.07% | 0.0 |
AEE Ameren Corporation | 4,867 | $508,017.28 | $529,626.94 | - | $21,609.66 | 4.25% | 0.0 |
AEIS Advanced Energy Industries Inc. | 3,091 | $1.03M | $1.04M | - | $17,470.91 | 1.7% | 0.0 |
AGM Federal Agricultural Mortgage Corporation | 1,117 | $193,879.94 | $265,901.85 | - | $72,021.91 | 37.15% | 0.0 |